USA - NASDAQ:CELZ - US22529Y4089 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to CELZ. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-02-25 | Roth Capital | Initiate | Buy |
7 analysts have analysed CELZ and the average price target is 20.4 USD. This implies a price increase of 568.85% is expected in the next year compared to the current price of 3.05.
The consensus rating for CREATIVE MEDICAL TECHNOLOGY (CELZ) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.